Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 20;216(11):587-593.
doi: 10.5694/mja2.51560. Epub 2022 May 29.

Management of atopic dermatitis: a narrative review

Michelle Sy Goh  1   2 , Jenny Sw Yun  1   3 , John C Su  4   5
Affiliations
Review

Management of atopic dermatitis: a narrative review

Michelle Sy Goh et al. Med J Aust. .

Abstract

Atopic dermatitis (atopic eczema) is the most common inflammatory skin disease and has a significant burden on the quality of life of patients, families and caregivers. Its pathogenesis is a complex interplay between genetics and environment, involving impaired skin barrier function, immune dysregulation primarily involving the Th2 inflammatory pathway, itch, and skin microbiome. Restoration of skin barrier integrity with regular emollients and prompt topical anti-inflammatory therapies are mainstays of treatment. Systemic therapy is considered for moderate to severe disease. New understanding of inflammatory pathways and developments in targeted systemic immunotherapies have significantly advanced atopic dermatitis management. Dupilumab is a safe and effective treatment that is now available in Australia. Other promising agents for atopic dermatitis include Janus kinase, interleukin (IL)-13 and IL-31 inhibitors.

Keywords: Dermatitis; Eczema.

PubMed Disclaimer

References

    1. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345-360.
    1. Lowe AJ, Leung DYM, Tang MLK, et al. The skin as a target for prevention of the atopic march. Ann Allergy Asthma Immunol 2018; 120: 145-151.
    1. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112: S118-S127.
    1. Martin PE, Koplin JJ, Eckert JK, et al. The prevalence and socio-dermographic risk factors of clinical eczema in infancy: a population-based observational study. Clin Exp Allergy 2013; 43: 642-651.
    1. Lopez DJ, Lodge CJ, Bui DS, et al. Establishing subclasses of childhood eczema, their risk factors and prognosis. Clin Exp Allergy 2022; https://doi.org/10.1111/cea.14139 [Epub ahead of print].

LinkOut - more resources